PMID: 7539867Jul 1, 1995Paper

Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers

The Journal of Urology
S ManiW J Poo

Abstract

Clinical characteristics prognostic of survival in patients with metastatic renal cell carcinoma treated with biological response modifiers are poorly understood. Understanding these prognostic features may help with better stratification of patients in clinical trials and define further appropriate treatment for each prognostic subgroup. A retrospective study of 84 patients with recurrent or metastatic renal cancer was conducted to identify prognostic factors for survival in patients who received biological response modifiers (alpha-interferon, beta-interferon, gamma-interferon and interleukin-2). Univariate analysis identified Eastern Cooperative Oncology Group (ECOG) performance status (1 versus 0, p < 0.001), bone metastasis (p = 0.008), recent weight loss (greater than 10% of total body weight versus no loss, p = 0.028), history of nephrectomy (no versus yes, p = 0.025), recurrence at the renal bed (p = 0.043) and sarcomatoid histology (yes versus no, p < 0.001) as important prognostic indicators. Multivariate analysis of prognostic factors in this patient population indicated that ECOG performance status, sarcomatoid histology and bone metastasis were most significant, while other factors were less significant (p > 0.05) ...Continue Reading

References

Sep 15, 1987·Cancer·A SellaM L Samuels
Dec 1, 1989·The Journal of Pediatrics·B S KaplanD S Rosenblatt
Jan 1, 1988·Seminars in Surgical Oncology·A de ForgesJ P Droz
Mar 15, 1988·Cancer·M Reis, V Faria
Aug 1, 1986·International Journal of Radiation Oncology, Biology, Physics·D GloverS Vogl
Nov 1, 1985·Equine Veterinary Journal·P J Brown, P E Holt
Apr 1, 1983·British Journal of Urology·P S Reddy, M V Merrick

❮ Previous
Next ❯

Citations

Apr 9, 1999·International Urology and Nephrology·M C UygurS Kendi
Jul 1, 2005·World Journal of Urology·Shomik SenguptaHorst Zincke
Jan 23, 2003·Current Urology Reports·Robert C Flanigan
Jan 23, 2003·Current Urology Reports·Dan LeiboviciAmnon Zisman
Jan 26, 2002·Nihon rinsho. Japanese journal of clinical medicine·T Takayama, K Fujita
Mar 31, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S T Tagawa
Nov 14, 1997·International Journal of Urology : Official Journal of the Japanese Urological Association·M TakashiM Ando
May 27, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Y Neuzillet, C Coulange
May 14, 2014·Clinical Genitourinary Cancer·Husain K KhambatiUNKNOWN International mRCC Database Consortium
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·F ArrouaC Bastide
Feb 12, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Anthony J PolcariRobert C Flanigan
May 8, 2001·Cancer Investigation·R D PastoreD M Nanus
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saminathan S NathanPatrick J Boland
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John S LamRobert A Figlin
Jul 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kazutaka NakayamaNaoto T Ueno
Oct 1, 2005·Urology·Shomik Sengupta, Horst Zincke
Oct 13, 2007·Critical Reviews in Oncology/hematology·John S LamRobert A Figlin
Apr 3, 2003·Clinical Orthopaedics and Related Research·Sung Taek JungSean P Scully
Jan 6, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·N KawataY Takimoto
Feb 10, 2004·The Journal of Urology·Robert C FlaniganE David Crawford
Apr 13, 2004·The Journal of Urology·Hyung L KimArie S Belldegrun
Feb 11, 2003·The Journal of Urology·Arnaud MéjeanNicolas Thiounn
Oct 5, 2001·The Journal of Urology·A J PantuckA S Belldegrun
Feb 23, 2002·Bone Marrow Transplantation·D A JacobsohnG B Vogelsang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.